Cargando…
Correction to: miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a
| Autores principales: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5907218/ https://www.ncbi.nlm.nih.gov/pubmed/29669588 http://dx.doi.org/10.1186/s13045-018-0599-z |
| _version_ | 1783315486710169600 |
|---|---|
| author | Cao, Man-Qing You, A-Bin Zhu, Xiao-Dong Zhang, Wei Zhang, Yuan-Yuan Zhang, Shi-Zhe Zhang, Kei-wei Cai, Hao Shi, Wen-Kai Li, Xiao-Long Li, Kang-Shuai Gao, Dong-Mei Ma, De-Ning Ye, Bo-Gen Wang, Cheng-Hao Qin, Cheng-Dong Sun, Hui-Chan Zhang, Ti Tang, Zhao-You |
| author_facet | Cao, Man-Qing You, A-Bin Zhu, Xiao-Dong Zhang, Wei Zhang, Yuan-Yuan Zhang, Shi-Zhe Zhang, Kei-wei Cai, Hao Shi, Wen-Kai Li, Xiao-Long Li, Kang-Shuai Gao, Dong-Mei Ma, De-Ning Ye, Bo-Gen Wang, Cheng-Hao Qin, Cheng-Dong Sun, Hui-Chan Zhang, Ti Tang, Zhao-You |
| author_sort | Cao, Man-Qing |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5907218 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-59072182018-04-30 Correction to: miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a Cao, Man-Qing You, A-Bin Zhu, Xiao-Dong Zhang, Wei Zhang, Yuan-Yuan Zhang, Shi-Zhe Zhang, Kei-wei Cai, Hao Shi, Wen-Kai Li, Xiao-Long Li, Kang-Shuai Gao, Dong-Mei Ma, De-Ning Ye, Bo-Gen Wang, Cheng-Hao Qin, Cheng-Dong Sun, Hui-Chan Zhang, Ti Tang, Zhao-You J Hematol Oncol Correction BioMed Central 2018-04-18 /pmc/articles/PMC5907218/ /pubmed/29669588 http://dx.doi.org/10.1186/s13045-018-0599-z Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Correction Cao, Man-Qing You, A-Bin Zhu, Xiao-Dong Zhang, Wei Zhang, Yuan-Yuan Zhang, Shi-Zhe Zhang, Kei-wei Cai, Hao Shi, Wen-Kai Li, Xiao-Long Li, Kang-Shuai Gao, Dong-Mei Ma, De-Ning Ye, Bo-Gen Wang, Cheng-Hao Qin, Cheng-Dong Sun, Hui-Chan Zhang, Ti Tang, Zhao-You Correction to: miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a |
| title | Correction to: miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a |
| title_full | Correction to: miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a |
| title_fullStr | Correction to: miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a |
| title_full_unstemmed | Correction to: miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a |
| title_short | Correction to: miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a |
| title_sort | correction to: mir-182-5p promotes hepatocellular carcinoma progression by repressing foxo3a |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5907218/ https://www.ncbi.nlm.nih.gov/pubmed/29669588 http://dx.doi.org/10.1186/s13045-018-0599-z |
| work_keys_str_mv | AT caomanqing correctiontomir1825ppromoteshepatocellularcarcinomaprogressionbyrepressingfoxo3a AT youabin correctiontomir1825ppromoteshepatocellularcarcinomaprogressionbyrepressingfoxo3a AT zhuxiaodong correctiontomir1825ppromoteshepatocellularcarcinomaprogressionbyrepressingfoxo3a AT zhangwei correctiontomir1825ppromoteshepatocellularcarcinomaprogressionbyrepressingfoxo3a AT zhangyuanyuan correctiontomir1825ppromoteshepatocellularcarcinomaprogressionbyrepressingfoxo3a AT zhangshizhe correctiontomir1825ppromoteshepatocellularcarcinomaprogressionbyrepressingfoxo3a AT zhangkeiwei correctiontomir1825ppromoteshepatocellularcarcinomaprogressionbyrepressingfoxo3a AT caihao correctiontomir1825ppromoteshepatocellularcarcinomaprogressionbyrepressingfoxo3a AT shiwenkai correctiontomir1825ppromoteshepatocellularcarcinomaprogressionbyrepressingfoxo3a AT lixiaolong correctiontomir1825ppromoteshepatocellularcarcinomaprogressionbyrepressingfoxo3a AT likangshuai correctiontomir1825ppromoteshepatocellularcarcinomaprogressionbyrepressingfoxo3a AT gaodongmei correctiontomir1825ppromoteshepatocellularcarcinomaprogressionbyrepressingfoxo3a AT madening correctiontomir1825ppromoteshepatocellularcarcinomaprogressionbyrepressingfoxo3a AT yebogen correctiontomir1825ppromoteshepatocellularcarcinomaprogressionbyrepressingfoxo3a AT wangchenghao correctiontomir1825ppromoteshepatocellularcarcinomaprogressionbyrepressingfoxo3a AT qinchengdong correctiontomir1825ppromoteshepatocellularcarcinomaprogressionbyrepressingfoxo3a AT sunhuichan correctiontomir1825ppromoteshepatocellularcarcinomaprogressionbyrepressingfoxo3a AT zhangti correctiontomir1825ppromoteshepatocellularcarcinomaprogressionbyrepressingfoxo3a AT tangzhaoyou correctiontomir1825ppromoteshepatocellularcarcinomaprogressionbyrepressingfoxo3a |